Skip to main content

Advertisement

SpringerLink
Log in

Early remission of type 2 diabetes mellitus by laparoscopic ileal transposition with sleeve gastrectomy surgery in 23–35 BMI patients

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

To assess the efficacy of ileal transposition with sleeve gastrectomy (SGIT) surgery in remission of Type 2 Diabetes Mellitus (T2DM) in patients with 23–35 BMI. Diabetes is considered a life style disease. Despite medications and lifestyle changes, (HbA1c) - remains > 7 in 56 % of diabetics, predisposing them to high risk of diabetes related complications. Bariatric surgery results in remission of diabetes in over 84% patients with BMI > 35 m2s/m2. Based on hindgut hypothesis suggesting role of incretins like GLP-1, early trials of ileal interposition surgery have displayed consistent HbA1c levels below 7 in over 80% patients with BMI > 30 m2/m2. In developing countries majority of T2DM patients are not morbidly obese and surgical procedures are to be evaluated for their efficacy in this group. In this study we have assessed the efficacy of ileal transposition with sleeve gastrectomy (SGIT) in 23–35 BMI T2DM patients. Selected T2DM patients [HbA1c > 7, C Peptide > -1 ng/ml] underwent Lap SGIT by a single surgeon. Data of first five patients with minimum 6 months follow up was analyzed for glycemic control and altered need for medications. Data were analyzed using SPSS (SPSS release 16; SPSS Inc. Chicago). The study target (HbA1c < 7) was achieved in 60% of patients within 1 month and in 100% of patients within 6 months. Requirement of medications reduced significantly within 6 months and their HbA1c levels reduced from 9.65% to 6.22%. Laparoscopic SGIT may represent a new paradigm for the treatment of T2DM even in non morbidly obese patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Banting FG, Best CH. The internal secretion of the pancreas. J Lab Clin Med. 1922;7:251–66.

    CAS  Google Scholar 

  2. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37:1595–607.

    Article  PubMed  CAS  Google Scholar 

  3. American Diabetes Association. Prevention or delay of type 2 diabetes. Diabetes Care. 2004;27(Suppl):S47–53.

    Google Scholar 

  4. Singh BM, Jackson DM, Wills R, Davies J, Wise PH. Delayed diagnosis of non–insulin-dependent diabetes. Br Med J. 1992;304:1154–5.

    Article  CAS  Google Scholar 

  5. Olefsky J, Nolan J. Insulin resistance and non–insulindependent diabetes mellitus: cellular and molecular mechanisms. Am J Clin Nutr. 1995;61:980S–6S.

    PubMed  CAS  Google Scholar 

  6. Arner P, Pollare T, Lithell H. Different aetiologies of type 2 (non–insulin-dependent) diabetes mellitus in obese and nonobese subjects. Diabetologia. 1991;34:483–7.

    Article  PubMed  CAS  Google Scholar 

  7. Gerich JE. Insulin resistance is not necessarily an essential component of type 2 diabetes. J Clin Endocrinol Metab. 2000;85:2113–5.

    Article  PubMed  CAS  Google Scholar 

  8. Vilsboll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, et al. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide regardless of etiology and phenotype. J Clin Endocrinol Metab. 2003;88:4897–903.

    Article  PubMed  CAS  Google Scholar 

  9. Luzi L, DeFronzo RA. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans. Am J Physiol. 1989;257:E241–6.

    PubMed  CAS  Google Scholar 

  10. Vilsboll T, Holst JJ. Incretins, insulin secretion, and type 2 diabetes mellitus. Diabetologia. 2004;47:357–66.

    Article  PubMed  CAS  Google Scholar 

  11. Zander M, Madsbad S, Madsen JL, Hoslt JJ. Effect of 6- week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta cell function in type 2 diabetes: a parallel-group study. Lancet. 2002;359:824–30.

    Article  PubMed  CAS  Google Scholar 

  12. Hickey MS, Pories WJ, MacDonald Jr m2, Cory KA, Dohm GL, Swanson MS, et al. A new paradigm for type 2 diabetes mellitus? Could it be a disease of the foregut? Ann Surg. 1998;227:637–44.

    Article  PubMed  CAS  Google Scholar 

  13. Greenway SE, Greenway FL, Klein S. Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg. 2002;137:1109–17.

    Article  PubMed  Google Scholar 

  14. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoellesk. Bariatic surgery: a systematic review and meta-analysis. JAMA 2004;292:1724–1737.

    Article  PubMed  CAS  Google Scholar 

  15. De Paula AL, Macedo AL, Prudente AS, Queiroz L, Schraibman V, Pinus J. Laparoscopic sleeve gastrectomy with ileal transposition (“neuroendocrine brake”): pilot study of a new operation. Surg Obes Relat Dis. 2006;2:464–7.

    Article  PubMed  Google Scholar 

  16. Paula AL, Macedo ALV, Rassi N, Machado CA, Schraiban V, Silva LQ, Halpern H. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc 2008;22:706–16.

    Google Scholar 

  17. American Diabetic Association. Standard of Medical Care in Diabetes – 2009. Diabetes Care. 2009;32 suppl 1:S13–61.

    Article  Google Scholar 

  18. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025; prevalence numerical estimates and projections. Diabetes Care. 1998;21:1414–31.

    Google Scholar 

  19. Health planning in North-East India: A survey on Diabetes Awareness, Risk Factor and Health Attitudes in a Rural Community Sue.L.Lal, Rati. Debaema, N.Thomas, HS Asha, KS Vasan, RG Alex, JAPI April 2009;57:305–309.

  20. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238:467–84.

    PubMed  Google Scholar 

  21. Torquati A, Lutfi R, Abumrad N, et al. Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg. 2005;9:1112–8.

    Article  PubMed  Google Scholar 

  22. Dixon JB, Pories WJ, O’Brien PE, Schauer PR, Zimmet P. Surgery as an effective early intervention for diabesity: why the reluctance? Diabetes Care. 2005;28:472–4.

    Article  PubMed  Google Scholar 

  23. Vidal J, Ibarzabal A, Romero F, Delgado S, Mombian D, Flores L, et al. Type 2 Diabetes Mellitus and the metabolic syndrome following Sleeve Gastrectomy in Severely Obese Subjects. Obes Surg. 2008;18:1077–82.

    Article  PubMed  CAS  Google Scholar 

  24. Rask E, Olsson T, Soderberg S, Holst JJ, Tura A, Pacini G, et al. Insulin secretion and incretin hormones after oral glucose in nonobese subjects with impaired glucose tolerance. Metabolism. 2004;53:624–31.

    Article  PubMed  CAS  Google Scholar 

  25. Bedno S. Weight loss in diabetes management. Nutr Clin Care. 2003;6:62–72.

    Google Scholar 

  26. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741–9.

    Article  PubMed  Google Scholar 

  27. Service GJ, Thompson GB, Service J, Andrews JC, Collazo-Clavell ML, Lloyd RV. Hyperinsulinemic hypoglycemia with nessidioblastosis after gastric-bypass surgery. N Engl J Med. 2005;353:249–52.

    Article  Google Scholar 

  28. John BB, Sonia C, Willam TC, Antonio C, Stefano DP, Silvio EI, et al. How do we define cure of diabetes ? Diabetes Care. 2009;22:2133–5.

    Google Scholar 

Download references

Acknowledgement

The source of funding to test all the patients for their follow ups was provided by Bombay Hospital & Medical Research Centre.

Conflict of Interest

The authors do not have any disclosable conflict of interest.

Author information

Authors and Affiliations

  1. Bombay Hospital, Mumbai, Maharashtra, India

    Ramen Goel, Pravin Amin, Madhu Goel & Sanjeet Marik

  2. Center for Metabolic Surgery, Mumbai, Maharashtra, India

    Madhu Goel

Authors
  1. Ramen Goel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pravin Amin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Madhu Goel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sanjeet Marik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ramen Goel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goel, R., Amin, P., Goel, M. et al. Early remission of type 2 diabetes mellitus by laparoscopic ileal transposition with sleeve gastrectomy surgery in 23–35 BMI patients. Int J Diabetes Dev Ctries 31, 91–96 (2011). https://doi.org/10.1007/s13410-011-0021-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-011-0021-7

Keywords

Search

Navigation